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Introduction: India has become the world hub for tuberculosis. According to the latest World HealtJi Organisation (•WHO) report titled "Global Tuberculosis Control 201 r'S.R million eases of TB are registered of wtiich 2.5 million were from India. India alone accounted for an estimated 26 % of all TB cases worldwide and remains a major killer, killing 2 persons every .1 minutes wliich is nearly I Ot)0/da>. Multidrug resistant tuberculosis (MDR TB) has evolved to become a serious threat lo the general public due t<i limited ircaimcnl options (I-Ching ci al, 2006; Morgan cl al, 2005) . In order lo have ellicicnl u-caimcni, il becomes imperative ihai dclcclion be done as early as possible. The emergence ol extensively drug rcsislanl uiberculosis (XDR TB) looms large in the backdrop of such scenario ^vilh further spread of drug resistance, especially in IllV-inlecled paiienLs, a.s wax recently rcporlcd (Oandhi2006).XDR TB, defined as MDR TB with additional resistance (o lluoroquinolonc anlibioiic and allcasl one ol'lhc ihrec injectable drug ased lor MDR TB treatment (Centre 1 & 2) has been idcntiUcd in X4 countries with an average proportion ol MDR TB cases with XDR TB as 9% (6.7 -11.2%) (WHO. 2012).
As such early detection of drug resistances constitutes one of the priorities ol" TB control programs. Detection of drug resistance has been performed in the past by coflventional methods based oiidelection of grcftlh of M.iubenulosis in the presence of antibiotics. Conventional indirect methods of detection for drag resistance take 10 -12 weeks for the sample to get dnig susceptibility (est (DST) report ivfiile direct method may be given by 4 -6 week (Canetti et al, 1963; Caviedes et al, 2002 ; Kent & Kubica, I9S5). However due to the labouriousness of some of this methods and most of all the long period of time necessaty to obtain rcsttlts, new technologies and approaches have been proposed which include both phenotypic and genotypie methods. In many eases, the genotypie methods i" particular have been directed towards detection of rifampicin (RIK) resistance, since it is considered a good surrogate marker for MDR TH, especially in settings with high prevalence of MDR TH (l-Chiiig et al, Morgan et al, 2005) . Genotypie methods have the advantage of a shorter turnaround time, no need ftrr eultur-c of organism, pos-sibility of direct application in clinical .saniplcs, lower liioha7ard risk and the feasibility of automaticni. However, not all mechanism of drug r-csistancesarc known. Genotypie mcdiods for drug resistance look for the genetic determinanLs of resistance rather than the www.rosrjoumals.oi'g 4 
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Analysis qfmuiaiionalpauern in muhidi-uf^ resisiani tuberculosis jMDR TH) in o f<eof;raphicaIly resistance phenotype and involve two basic steps -nucleic acid amplification by polymeinse chain reaction (PCR) to ampliiy the sections of tlie M.ltiberculosis genome know to be altered in resistant strains and a second step of assessing tlie amplified products for specific mutations correlating with drug resistance (Garcia de Viedina, 2003; Palomino, 2005) . Nearly all RJF resistant strains contain mutation of the rpoB gene wbile mutations iji the emhB gene were associated with ethambutol (EMB) resistance (Cole, 1996; Riccardi et al, 2009 ). Mutations in katG gene and inhA gene were relate to tlie high level and low level isoniazid (IKH) resistance respectively (Vilche7e and Jacob, 2007). I'he nature and frequency of mutations in tlie resistant strains vary significantly based on tiie geographical location (Mokrousov et al, 2002) . There is very less infonnation available on specific mutational patterns in India (Shanna et al, 2003) , let alone on the underdeveloped and isolated region of nortJieast India. MDR IB strains have been reported mostly from countries where HIV and IB co-infection is endemic which includes India (Prasad, 2005) . The dual challenges in TB and IITV eo-inrcclions are particularly pressing in Manipur, a stale in the ca.slcrnmosi corner of norlhca,sl India which has the highest estimated aduli IIIV prevalence in India (NACO India, 2012)
The present study is being underlakcn with an aim lo extend the knowledge ofmuiaiional pailcm of M.tiiherculnsis-complex by using ilie MTBDR/)//« and MTBDR.?/(IIain Lireseicnec) in Manipur, a geographically i.TOlalcd region of northeast India. The study also evaluates the MTBDR method by comparing with phenolypic culture based method (BacT Alen 3D) on an aiiempi to highlighi the feasibility of applications in the current situation of TB. it,s drug resistance and diagnostic (rends in northeastern India.
Material And Methods Study settings.
This study was conducted at the Babina Diagnostic Centre in Imphal, Manipur which is one of the irto.st prominent and main referral diagnostic lab of the region. It currently serves a population of 2.7 million. Testing was performed on residual portions of routine clinical specimens submitted for culture and DST. Informed consent was not taken for the study as results were unlinked from patient identifiers and no patient information was collected. Only one sample per (xitienl was collected. Sputum .sjwcimens Three hundred and .seventy live sputum samples were collected between May -December 2011. Every handling of the clinical specimeas «as conducted inside a Cla.ss II safely cabinet in aBSL2 laboratory in accordance with CDC guidelines. Sputum dccontaminaliotis were carried out with the conveolional N-acelyl-Lcysieine-NaOH. After cenlrifugalion, the |iellel was suspended in 1ml of S5% NaCI. .Ml specimens were processed for acid fast microscopy using Ziel-Neesen technique (Caiietti et al. 1963; Kent & Kubica. 1985) . Sputum samples showing more than 10 acid fast bacilli (AFB) per microscopic field in the smear were selected for the study.
BacT/Alert .3D culture and DST
Drug susceptibility testing for isoniazid, rifampicin and ethambutol was performed by BacT/.\leit 3D system. A 0.5ml portion of the sediment was inoculated into the vials of RacT/Alert 3D system containing modified Middlebrook 7H9 media with respective antibiotic. The final drug concentration in the test bottles was lug/ml for INH and RIK and 2lug ml for KMH. All mycobacterial cultures were incubated at 37°C and were continuously monitored.A/.iu6era//o.rii isolate was determined to be resistant to the antibiotic when the drug containing bottle had a lime to detection (TTD) that was less than or equal to the TTI) of I % contiol. Genotype MTBDR/J/M and MTBDRv/ DST The MTBDR;5lus and MTBDR,«/ DST were performed according to the manufacturer's instiuction and are divided into tliree steps: DNA extraction, a multiples aniplifieaticm using biotinylated primers and reverse hybridisation. A 500^1 porticm of tlie decontaminated sediment was u.sed for DNA exUaetion using modified CTAB-NaCI method. The isolated DNA samples from the process mentioned above were used for multiplex amplification with biotinylated primers. The hiotin labelled PCR product was eheniieally denatured and hybridised lo ilie su-ip with specific oligonucleotide probes. Allcr hybridisation and wa.shing, strips were removed, allowed in dry and fixed on the nitrocellulose paper. All samples that tested positive for MDR in the MTBDRp/"-' strip was liirlhcr subjected ui MTBDR.v/ test. Phenolypic DST was conducted for EMB only in the MDR strains which has been subjected MTBDR.t/. All icsis were performed independent of culture and DST.
Interpretation of results
Each strip in MTBDR/'/i" consist oD7 reaction zones (bands) including six controls (conjugate , amplification, M.tuberculosis complex, rpoB. hiHj and inh.\ controls), eight rpoB iJild type (\VT) and four mutant (MUX) probes, one kuiO wild type and hvo mutant and two inhA wild type and four mutant probes susceptible strains including 13 culture negative strains while Bac'l/Alert system could detect 264 susceptible .•rtrains including 9 unintcrprctahic strains of MTBDR/)/i«. The .scn.sitivily, specificity, accuracy, positive predictive values (PPV) and negative predictive values (NPV) arc given in Table 2. BQCT/Alert culture and DST for smcai' positive specimens hod a Uitai turnoi'ound time of R -12 day.s. For MTBDR/)/;w testing, the test Kicik 1 -2 days for smear positive results while MTBDR.^/ U;.sting of the MDR suains ttKik another 2 days.
Toble 3 shows the distribution of different banding patterns in drtig resistant isolates, including NfDR, INH raonoresLStanl and RIF monoresislanl strains while Table 4 shows the banding pailera of MDR Lsolalrs which has been subjected lo MTBDR.9/ lesL Typical banding pallems obtained on MTBDR/J/IK and MTBDR.^/ suips are shown in Figure 1 .
The RIF rcsLSianl isolates displayed different mutations. The most common mutation was in the S531L region (MUT3) with 45.6% of all RIF resislani strains (55% of MDR and 19% of RJF monoresistant suains) having the mutation in the kulO codon with amino acid change of Ser-3I5-Thrl. This difference in prevalence of the S531L mutation between MDR and RIF monoresistant strain was signiUcant I? -0.012). Two MDR strain had a D516V mutation (3.4% overall). Of the isolates with mutation in the wild type probes, mutation in the WT8 was most common, as detected by the lack of binding to the WT8 probe in the absence of S531L mutation except for one strain which had both die WT8 wildtype and the S531L mutation. No mutation was delected in the MUT2A andMUT2B b.ind in bodi the RIF monoresistant and MDR strains. There was no significant difference in the presence of other bands between MDR and RIF monoresistant strains. Of all the INH resistant strains, 73% (71% of MDR and 81% of INH monoresistant strains) had a mutation in the katO S3I5TI region wtiile 4"'o hatl a mutation in the S315T2 region indicating high level resistance wliile I9%(19% Of MDR and 19% of INH itionoresisTant strains) had mutation in the CI5T region of inhk gene indicating low level resistance. This difference in prevalence of mutations in MDR strains compared with INH monoresistant stiains was significant for kaiG (P = 0.0073) but not for <' n/;A ((' = 0.1497). Hive strains had mutations in both tfic kalCi and/rt/;Agcncs. Seventy .six percent (28 37) of MDR .strains hpd a mutation in the katCt gene and were detected as INH resi.stant y a niuUition in tlie katC, gene. Only three of Ifi (18.8%) TNH monorcsi.stant .strains \*-crc detected by the presence of a mutation in inhA only Genotype MTBDR.?/ testing from MDR positive .samples.
All samples tested for XDR hy MTBDR\7 were fortunately negative \»1iich indicates that XDR is not yet detected from this region. This non-detection of XDR was all due to no mutation being detected in the rrx gene probe while mutation was delected in all ihc muialion region of ^•i A gene with Ihc highest rale in the D94G region (17%). One IvfDR positive strain had a «,ITA MUT3D muialion. This is a rare muialion which has been dclccicd only in silica and hence thought tii he undetectable in \-itio. Bui Uiis dctcclion albeit in one strip proves dial iv is delectable and that Uic MTBDR.sf is cITicicnt in dclccling even rare mouiions. Of ihc 32 EMB rcsisuni strains according to ihc molecular mciliod, 5 strains had mulalions in Ihc cmh\i gene region of codon 306 «iih amino acid change of Mci-306-Ilc and 27 strain had muialion in ihc «iiAB gene with amino acid change of Mel-306-Val. One strain had mutation lliai was detected only at the u-ild type probes (enibQ WT) but not at the mutant probes. The performance characteristics of specificity, seasiiivity. accuracy, PPV and NPV as given in Table 2 suggest that the MTBDR . Three out of 16 INH monoresistant strains were delected by mutations in inhA gene only. These mutations would not have been delected by the previous MTBDR which didn't incorporate the inliA probe. As such, mutations in other genomic regions might be inducing resistance to INH which would not be detected by genotypic method if their corresponding probes were not included, leading to false positives apart from the false negative results due to presence of inhibitors (Palomino, 2006) . Identification and drug resistance assay of M.tuberculosis normally requires several «eeks as they are very slow in their growth and even with automated culture system, it takes an average of 14 days. Another 14 days for additional tests are requiretl for DST. Moreover, the culture based methods involve increased consumption of exclusive culture media and hence place more economic burden on patients especially in a low resource and high burden region like Manipur. On the bxsis of FIND-negotiated prices, the cost of molecular as.say is less than 50% of that for conventional liquid culture and DST for INH and RIT (Barnard e-t al,2008) Therefore there is urgency for an efficient method of TB testing as a complement to conventional culture and smear iiiicro.saipy.
In conclusion, the results of this study suppoits the use of MTBDR/i/iiv for rapid diagnosis of TB considering the drastic reduction of time in diagnosis and its uecuraey being aimparable to conventional methods. It might also be more cosi cflcctivc in the long run. This molecular gcnoiyping »ill al.so be useful in studying epidemiological and mutaiional analysis ni \^.luhL-rculi>sis ofspccific regions. 
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Analysis oj mulalional pailem in muhidi-ua resisiani tuberculosis (MDR TH) in a /jeofiraphicaUy
Comparison of drug susceptibility pattern oi Mycobacterium tuberculosis assayed by MODS (Microscopic-observation drugsusceptibility) with that of PM (proportion method) from clinical isolates of North East India
ABSTRACT:
About one third of the world's population are iifecled with tuberculosis and has become a serious global concern of public health. The major problem in controlling tuberculosis is the rapidity and efficacy of detection methods adopted, this study was conducted with the objective to compare the drug . INTRODUCTION Tuberculosis arouses public health concern and became a global burden It is about one third of the population of the world are infected with tuberculosis. AlOS and the increase incidence of multidjug resistant Uibcrculosis arc the major Ihcuirs thai conu-ibutc to uibcrculosis epidemic. In 2012, S.6 million people Icll ill with TB and 1.3 million died (WHO, 2013).TR occurs in every part of the world. In same year ihe larjicst number of now TT3 ca.'ics occurred in Asia, accounting lor 60% of new cases globally. However, sub-Saharan Africa can-ied the greatest proportion of new cases per population with over 255 cases per 100000 populations in 2012 (WHO, 20n).
siL'iccplihility pattern if Mycnhactcrium tuberculosis assayed hy MODS (Micritsciipic-ohservatiim ih-ugsusceplibiliiy) with that of HM (proportion method) from clinical isolates of
In 2012, about 80% of reported TB cases occurred in 22 countries. Some countries are experiencing a n\ajor decline in cases, while cases are droppiiij: very slowly in others (WHO.2013). India is classified along with the sub-Satiaran African countries to be among those with a high hurdcnibr lubcrculo.si.'i as «ell a.s drugresistant tuberculosis fWHO, 2012). Though India is the second-most populous country in the world, India has more new TB co.scs annually than any oihcrcouniry. In 2011, oul of the estimated global annual incidence or9 luiUioD TB cases, 2} million were estimated to baveoccuirert in India (WHO, 2013).The nature and frequcocy of mutations in the resistant strains vary significantly based on the geographical location (Mokrousov ct al, 2002). In this regard, here is very less information available on specific mutational patterns in India (Sbarma el al, 2003), let alone on the underdeveloped and Isolated region of northeast India. MOR IB strains have been reported mostly from countries where Hl^' and TB eo-iofection is endemic wliich includes India (Prasad, 2005) . The incidence:prevalence ratio in India is about 1:32, hi case an efficient tuberculosis programme, targeting a su(Ticicnt number of.sputum-positive prevalence ca.scs in the community, is run for a .sufficiently long period of time, it could bring down the prevalence, till probably die point when incidence and prevalence become equal in the community (N.ACO India, 2012). With an increase in the drug resistance of the Tubercle bacilli, the conurol of tuberculosLs becomes more diQlcull.
In the present study comparative analysis has been carried out between conventional proportion method (PM) and Micr(t.scopic-obsci^*ation drug-susceptibility (MODS) a.s.say (New Rapid Susceptibility Test
). This suidy also helps in increasing the uniierstanding of IB occurrence anil tletection methixis in NK Inilia.
n. MATERUL AND METHODS 2.1
Study .settings The clinical isolates referred tn the Babina Diagno.stic Ccntie in Imphal, Manipur were taken up for the present study. In order to strengthen the rapid detection of drug susceptibility o( Myu>hactcriinn tuherculcun.'! at resources limited anil high burden region the study was carried out.
2.2
.Sputum specimens One hundred and filh' sptittim samples were collected for this study. Entire handling of the clinical specimens was performed inside a Class II .safety cabinet in a BSL2 laboratory in accordance with CDC guidelines. Sputum decontaminations were carried out with the con\'cntional N-acclyl-L-cyslcinc-NaOII. .M'lcr centrifiigation, the pellet svas suspended in hnl of 85% NaCl. All specimens were processed for acid fasi microscopy u.sing Zicl-Necscn technique (Caneui ct al, 19(i3; Kent &Kubica, 19X5). Sputum samples showing more than 10 acid fasT bacilli (AKB) per microscopic field in the smear were selected for the study.
J Critical concenlralion of antibiotics In Drug .Susceptibility Testing
The critical concentration of antibiotics which is given below Table. I were maintained as per prescribed norms for indirect DST assay for PM and MOD.S methods. Comparison ofdntg susceptibility pattern..
Bacterial suspension for inoculation:
Approximately hnj! moist weiglit of representative sample of llie bacterial mass visuxlized as 2/3 loopful nr3tntn inlcmal diameter is added U) 0.2ml ofslcnlc distilled water in a 7ml Bijou holllc amiaining 10-12 glass beads. This mixture is vorle.xed for approxitnately 30 seconds to gel unilorm suspension The suspension is then made up to approximately Img/ml concentration by adding more distill water and then kept on the bench for 15-20miii to allow coarser particles to settle down. From this suspension, a len-1'old serial dilution is made by adding 0.2ml to I.Snil sterile distill water, l-ach serial dilution suspension was inoculated by one standard loopful on to Ihe drug-liee as well as the drug-conlainiiig LJ slopes
2.4.3
Intcrprctatiun of results:
The results are read for the first time on the 28th day. Colonies arc counted only on slopes seeded with an inoculum that has produced exact readable counts or actual counts (up to 100 colonics on die slope). This inoculum may be the same for the control slopes and the di-ug-coatainiiig slopes, or it may be the low inoculum (10"*" mg of bacilli) for the ctmtrol slopes and the high inoculuir (10 mg of bacilli) for the drug-ct)ntaining slopes. The average number of colonies obtained for the drug-containing slopes indicates the number of resistant bacilli contained in the inoculum. Di\iding the second figure by the first gi\es the pr(tportion of resistant bacilli existing in die strain. Below a certain value -die critical proportion -the su-ain is classilied a.s ^en.silive; above tliat value, it is classitled as resistant, I he proportions are reported as percentages. If, according to the criteria indicated below, the result of the reading made on the 2i<ih day is "'lesislanl", no furdier reading of the test for tliat drug is required and the strain is classified as resistant. If the result at the 28th day is "sensitive", a second redding is made on the 42nd day and this provides the dellnitive result. .\ny strain \vith 1% (the critical proportion) of bacilli resistant to any of the four drugs -rifampicin, isoniazid, ethambutol, and streptomycin is classified as resistant to that dmg. For calculating the propoilion of resistant bacilli, the highest counts obtained on the drug-free and on the drug-containing meditim should be taken, regardless of whether both counts are obtained on tiie 28th day, botii on the 42nd day, or one on the 28th day and the other on the 42°''.
2.5
Microscopic observation drug .susceptibility assay (MODS)
The procedure was carried out os described by Moore et al (2006) . MOD.S is conducted using Middlcbrook 7TI9 media. Culture preparation was done by dissolving 5.9g of 7119 medium powder in 900 ml ol sterile dw (distilled water) containing 3.1 ml of glycerol and 1.2Sg orca.silonc along w-ilh PANTA (polymyxin, ampholcricin, nalidixic acid, Irimcthoprim, azlocillin)-lo minimize contaminalion olMODS culture by oral llora micro-organisms not killed during decontamination process. Finally, 100(11 fNII 4(ig ml (Sigma) or lOOjil RIII 10 ng/ml (Sigma) was added lo the INlI-coniaining well and Rlll-comaining well, respectively. The linal conccntralion.s of 0.\DC (oleic acid dextrose calalasc) and PANTA in each well were 10% and 20 jil/ml.respeclively. The drug concenU"ations in each well were tnainlained as per given in Table. 1 and incubated al 37X1^48 hr to verity sterility (lack of turbidity).
2.5.1
Bacterial suspension for inacniatinn: Mix 10 ml sterile dw and 40 p.1 of 10% .sterile Tween 80 in a sterile tube (fmal Tween 80 concentration = 0.04%). Using a sterile loop, harvest several colonies oiMycobucteria and place in a sterile tube containing 100 pi water-Tween 80 solution and sterile glass heads. Cap die tube tightly and vortex for 2-3 min (till there are no visible clumps) Let it stand for i rain and the open tube and add 3 ml of waler-Tween 80. Cap tightly and voitex again for 20s (till sus(x;nsion has uniform turbidity). Let it stand for 30 min. Transfer die supernatant to another sterile tube using a pipette. Adjust turbidity to McFarland Scale 1 (approximately 3x10 CFU/ml) with 0.04% water-Tween 80 solution.
2.5.2
Plate settlnR for MOD.S: A 24 well plate is taken and marked for controls and drugs-containing wells. 900ul of the ctilture media is di.spen.scd on to ihc wells and die required drug eonecnuations arc added for drug containing well. The liquid inoculums is dien added to make a final volume of 1ml The plates arc then closed with its lids and scaled with paraffin or with 7ip lock bags and incubated at 37"C (.Sarman cl.al: 2012).
Comparison ofdtvg susceptibility pattern..
2.S.3 Interpretation of rvsults:
The culture is dclcrtnincd in be susceptible when no grmvih is observed in Ihe bolh ihc wells. If one well in either Ihe drug wells has > 2cfii growth while the other well lias no gfowtli or is imennediale (Slcfii is icrtned as intcrmcdiaie), then the culture is termed as tnonoresistanl lo the drug with growth. If bolh the drug containinj! well of the culttue lias growth > 2cfu then it is considered resistant to both the drugs and is confirmed to be MDR. Table 4 ). The results of the PM arc taken as gold .standard for comparison to tliot of MODS. Table 6 .
T\.
DISCUSSION Our data shows that MODS is a sensitive and rapid method for diagnosis of TB and DST pattern. The sensitivities in detection of INH and RIH resistance in our study were lower tlian those from the study of Moore at el 2000 (72.6% vs 84.6°(. for INH and 72.7% vs 100% for RIH) although both studies used the same INH ainecntnitit)n (0.4pg ml) and RIP concentration (Ipg/ ml). These conecnti'ations have been rcenmmcnded in the MODS guidclinas from ihc MODS devclopmcnl learn in Peru (Jorge ei al; 2009. However, a recent metaanalysis published arter completion of this study concluded that the sensitivity of INH-resistance detection was higher «iih a concentration ofO. Ijig/ml without loss of spccilicity (Minion el al., 2010) .The only equipment needed to perfonn die MOOS assay are an inverted microscope, tissue culture plate and consumables, biological safely cabinet and Incuhalnr. The technical competence required is a.scpiic technique and microscopy skills. A commercial MODS plate (TB MODS kit™) has been developed by Hardy Diagnostics, USA in collaboration viiih PATH and is under evaluation.
V.
CONa.USION In conclusion MODS is appropriate for screening for DST palteni in high burden countries wliere such tests are urgently needed. MODS meets many criteria for an DST diagno.stie test applicahle for high-burden settings; it is rapid,, low a)S*t and accurate and can he performed without the need for biological .safety level 3 laboratories (if d\c plate is not opened afler inoculation). Therefore, MODS is an allcrnative method for rapid nS'l' screening inthcsc settings. Recently, wide application of MODS in resource-constrained settings has been endorsed by WHO |20ni. However, an international standard operating procedure and a quality assurance sy.sicm accredited hy WHO should he developed lo standaidi/c and maintain accuracy.
